On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
June 22, 2016
MQA Online Services will be unavailable from 6PM on Saturday, June 25th to 8PM on Tuesday, June 28th 2016 for system upgrades. Continue reading
June 17, 2016
As we mourn the tragic events that occurred in Orlando over the weekend, the Division of Medical Quality Assurance joins friends and colleagues in Central Florida and across the state to thank the dedicated health care professionals who have so … Continue reading